Mehal WZ - Search Results

1

Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH).

Do A, Zahrawi F, Mehal WZ. Do A, et al. Among authors: mehal wz. Nat Rev Drug Discov. 2024 Nov 28. doi: 10.1038/s41573-024-01084-2. Online ahead of print. Nat Rev Drug Discov. 2024. PMID: 39609545 Review.

2

Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in Steatohepatitis.

Ouyang X, Han SN, Zhang JY, Dioletis E, Nemeth BT, Pacher P, Feng D, Bataller R, Cabezas J, Stärkel P, Caballeria J, LePine Pongratz R, Cai SY, Schnabl B, Hoque R, Chen Y, Yang WH, Garcia-Martinez I, Wang FS, Gao B, Torok NJ, Kibbey RG, Mehal WZ. Ouyang X, et al. Among authors: mehal wz. Cell Metab. 2018 May 1;27(5):1156. doi: 10.1016/j.cmet.2018.04.007. Cell Metab. 2018. PMID: 29719229 Free article. No abstract available.

3

Adenosine deamination sustains dendritic cell activation in inflammation.

Desrosiers MD, Cembrola KM, Fakir MJ, Stephens LA, Jama FM, Shameli A, Mehal WZ, Santamaria P, Shi Y. Desrosiers MD, et al. Among authors: mehal wz. J Immunol. 2007 Aug 1;179(3):1884-92. doi: 10.4049/jimmunol.179.3.1884. J Immunol. 2007. PMID: 17641055

4

Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9.

Garcia-Martinez I, Santoro N, Chen Y, Hoque R, Ouyang X, Caprio S, Shlomchik MJ, Coffman RL, Candia A, Mehal WZ. Garcia-Martinez I, et al. Among authors: mehal wz. J Clin Invest. 2016 Mar 1;126(3):859-64. doi: 10.1172/JCI83885. Epub 2016 Jan 25. J Clin Invest. 2016. PMID: 26808498 Free PMC article.

5

Activation-induced cell death of hepatic stellate cells by the innate immune system.

Mehal WZ. Mehal WZ. Gastroenterology. 2006 Feb;130(2):600-3. doi: 10.1053/j.gastro.2005.12.048. Gastroenterology. 2006. PMID: 16472612 No abstract available.

6

Incorporating Weight Loss Medications Into Hepatology Practice for Nonalcoholic Steatohepatitis.

Do A, Kuszewski EJ, Langberg KA, Mehal WZ. Do A, et al. Among authors: mehal wz. Hepatology. 2019 Oct;70(4):1443-1456. doi: 10.1002/hep.30658. Hepatology. 2019. PMID: 30991446 Free PMC article. Review.

7

Drug development of nonalcoholic fatty liver disease: challenges in research, regulatory pathways, and study endpoints.

Do A, Ilagan-Ying YC, Mehal WZ, Lim JK. Do A, et al. Among authors: mehal wz. Expert Opin Drug Discov. 2021 Feb;16(2):125-134. doi: 10.1080/17460441.2020.1811674. Epub 2020 Oct 22. Expert Opin Drug Discov. 2021. PMID: 33086894 Review.

8

US mortality trends from alcohol-associated hepatitis by sex, age, race, and ethnicity, 1999-2020.

Banini BA, Chauhan S, Amatya A, Dashti F, Zahrawi K, Zahrawi F, Mehal WZ, McKee SA. Banini BA, et al. Among authors: mehal wz. Alcohol Clin Exp Res (Hoboken). 2024 Dec 30. doi: 10.1111/acer.15515. Online ahead of print. Alcohol Clin Exp Res (Hoboken). 2024. PMID: 39739407

9

Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ, Camporez JP, Shulman GI, Gordon JI, Hoffman HM, Flavell RA. Henao-Mejia J, et al. Among authors: mehal wz. Nature. 2012 Feb 1;482(7384):179-85. doi: 10.1038/nature10809. Nature. 2012. PMID: 22297845 Free PMC article.

10

The Gordian Knot of dysbiosis, obesity and NAFLD.

Mehal WZ. Mehal WZ. Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):637-44. doi: 10.1038/nrgastro.2013.146. Epub 2013 Aug 20. Nat Rev Gastroenterol Hepatol. 2013. PMID: 23958600 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters